114 related articles for article (PubMed ID: 22407820)
1. Adalimumab therapy in Crohn's disease of the ileal pouch.
Li Y; Lopez R; Queener E; Shen B
Inflamm Bowel Dis; 2012 Dec; 18(12):2232-9. PubMed ID: 22407820
[TBL] [Abstract][Full Text] [Related]
2. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch.
Shen B; Remzi FH; Lavery IC; Lopez R; Queener E; Shen L; Goldblum J; Fazio VW
Aliment Pharmacol Ther; 2009 Mar; 29(5):519-26. PubMed ID: 19183338
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.
Ferrante M; D'Haens G; Dewit O; Baert F; Holvoet J; Geboes K; De Hertogh G; Van Assche G; Vermeire S; Rutgeerts P;
Inflamm Bowel Dis; 2010 Feb; 16(2):243-9. PubMed ID: 19637335
[TBL] [Abstract][Full Text] [Related]
4. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
Nobile S; Gionchetti P; Rizzello F; Calabrese C; Campieri M
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.
Gregory M; Weaver KN; Hoversten P; Hicks SB; Patel D; Ciorba MA; Gutierrez AM; Beniwal-Patel P; Palam S; Syal G; Herfarth HH; Christophi G; Raffals L; Barnes EL; Deepak P
Inflamm Bowel Dis; 2019 Aug; 25(9):1569-1576. PubMed ID: 30810748
[TBL] [Abstract][Full Text] [Related]
6. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
[TBL] [Abstract][Full Text] [Related]
7. Elective switching from infliximab to adalimumab in stable Crohn's disease.
Hoentjen F; Haarhuis BJ; Drenth JP; de Jong DJ
Inflamm Bowel Dis; 2013; 19(4):761-6. PubMed ID: 23446337
[TBL] [Abstract][Full Text] [Related]
8. Long-term durability of response to adalimumab in Crohn's disease.
Chaparro M; Panés J; García V; Merino O; Nos P; Domènech E; Peñalva M; García-Planella E; Esteve M; Hinojosa J; Andreu M; Muñoz F; Gutiérrez A; Mendoza JL; Barrio J; Barreiro-de M; Vera I; Vilar P; Cabriada JL; Montoro MA; Aldeguer X; Saro C; Gisbert JP
Inflamm Bowel Dis; 2012 Apr; 18(4):685-90. PubMed ID: 21618353
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
Seo H; Ye BD; Song EM; Lee SH; Chang K; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK
Dig Dis Sci; 2017 Oct; 62(10):2882-2893. PubMed ID: 28822006
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.
Weaver KN; Gregory M; Syal G; Hoversten P; Hicks SB; Patel D; Christophi G; Beniwal-Patel P; Isaacs KL; Raffals L; Deepak P; Herfarth HH; Barnes EL
Inflamm Bowel Dis; 2019 Mar; 25(4):767-774. PubMed ID: 30295784
[TBL] [Abstract][Full Text] [Related]
11. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab induces deep remission in patients with Crohn's disease.
Colombel JF; Rutgeerts PJ; Sandborn WJ; Yang M; Camez A; Pollack PF; Thakkar RB; Robinson AM; Chen N; Mulani PM; Chao J
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):414-22.e5. PubMed ID: 23856361
[TBL] [Abstract][Full Text] [Related]
13. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review.
Godoy-Brewer G; Salem G; Limketkai B; Selaru FM; Grossen A; Policarpo T; Haq Z; Parian AM
J Clin Gastroenterol; 2024 Feb; 58(2):183-194. PubMed ID: 36753457
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres.
Tursi A; Elisei W; Picchio M; Penna A; Lecca PG; Forti G; Giorgetti G; Faggiani R; Zampaletta C; Pelecca G; Brandimarte G
Eur J Intern Med; 2014 Jun; 25(5):485-90. PubMed ID: 24631020
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease.
Bodini G; Giannini EG; Savarino V; Del Nero L; Pellegatta G; De Maria C; Baldissarro I; Savarino E
Scand J Gastroenterol; 2016 Sep; 51(9):1081-6. PubMed ID: 27207330
[TBL] [Abstract][Full Text] [Related]
16. Management of Crohn's disease of the ileoanal pouch with infliximab.
Colombel JF; Ricart E; Loftus EV; Tremaine WJ; Young-Fadok T; Dozois EJ; Wolff BG; Devine R; Pemberton JH; Sandborn WJ
Am J Gastroenterol; 2003 Oct; 98(10):2239-44. PubMed ID: 14572574
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of infliximab maintenance therapy for perianal Crohn's disease.
Uchino M; Ikeuchi H; Bando T; Matsuoka H; Takesue Y; Takahashi Y; Matsumoto T; Tomita N
World J Gastroenterol; 2011 Mar; 17(9):1174-9. PubMed ID: 21448422
[TBL] [Abstract][Full Text] [Related]
18. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
[TBL] [Abstract][Full Text] [Related]
19. A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease.
Macaluso FS; Ventimiglia M; Fries W; Viola A; Sitibondo A; Cappello M; Scrivo B; Busacca A; Privitera AC; Camilleri S; Garufi S; Di Mitri R; Mocciaro F; Belluardo N; Giangreco E; Bertolami C; Renna S; Orlando R; Rizzuto G; Cottone M; Orlando A;
J Gastroenterol Hepatol; 2021 Jan; 36(1):105-111. PubMed ID: 32428981
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.
Barreiro-de Acosta M; García-Bosch O; Gordillo J; Mañosa M; Menchén L; Souto R; Marin-Jimenez I;
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):756-8. PubMed ID: 22395225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
